Infratil (IFT) H1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2027 earnings summary
18 Nov, 2026Executive summary
Proportionate operational EBITDAF rose 28% YoY to NZ$711m, led by CDC and supported by One NZ and Longroad; FY27 guidance increased to NZ$1.37bn–NZ$1.44bn.
Portfolio asset value rose 8% to NZ$22.3bn; net portfolio asset value after fees was NZ$17.94 per share.
Strategic priorities emphasize scaling data centre and renewable positions, while pursuing selective opportunities and portfolio divestments.
Financial highlights
Proportionate operational EBITDAF was NZ$711m, up NZ$156m or 28% YoY; HY26 comparatives were restated to exclude divested assets.
Proportionate capital expenditure rose 98% YoY to NZ$2,143m, mainly reflecting CDC development and Longroad construction.
Net parent loss was NZ$248m, including a NZ$256m incentive-fee provision subject to year-end valuations.
Interim dividend was 7.4 cents per share, including 1.2 cents of imputation credits; payable 21 December 2026, with a 2% DRP discount.
Operating revenue was NZ$1,585.8m; continuing operations reported a NZ$233.6m net loss and continuing-operations EPS of (24.8)c.
Outlook and guidance
FY27 proportionate operational EBITDAF guidance increased to NZ$1,370m–NZ$1,440m from NZ$1,320m–NZ$1,420m; proportionate CapEx guidance rose to NZ$4,150m–NZ$4,450m.
CDC FY27 EBITDAF guidance increased to A$730m–A$770m; 1.1GW of contracted capacity is expected to generate A$2.2bn annualised EBITDAF when deployed by end-FY29.
Longroad targets over 14GW operating and under construction by end-2029, with projected operating fleet run-rate EBITDAF of ~US$1.2bn.
One NZ narrowed FY27 EBITDAF guidance to NZ$610m–NZ$640m; Qscan guidance was reduced to A$75m–A$85m from A$90m–A$105m.
Medium-term plans include potential divestments exceeding NZ$1bn; CDC is expected to become a cash flow contributor.
Latest events from Infratil
- Higher yields offset CDC's pipeline growth, leaving valuation broadly flat at A$18.45bn.IFT
Investor presentation - AI infrastructure and renewables anchor growth, led by CDC and Longroad.IFT
Investor day 2026 - Strong financials, portfolio growth, and strategic focus on renewables and data centres highlighted.IFT
AGM 2026 - Earnings up 11%, asset value up 13%, and FY27 guidance signals strong growth ahead.IFT
H2 2026 - Strong growth, sustainability, and AI readiness drive industry-leading performance and outlook.IFT
Investor presentation - Net profit surged to NZ$631.5m, with 7% EBITDAF growth and major digital and renewables gains.IFT
H1 2026 - EBITDAF up 25% year-over-year, $1.275B equity raise, and robust digital and airport growth.IFT
H1 2025 - Strong FY2024 results, digital/renewables growth, and board alignment drive future strategy.IFT
AGM 2024 - EBITDAF up 8.6% to NZD 986m, portfolio value up 29%, with strong growth outlook.IFT
H2 2025